EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Pfizer Inc. $PFE Shares Sold by Canal Insurance CO
Symbol: ZPFE Security name: Pfizer (PFE) BMO CDR (CAD Hedge
Should Pfizer's Oncology Win And Obesity Push Require Action From Pfizer (PFE) Investors?
Promising Pharmaceutical Stocks To Add to Your Watchlist - January 13th - Markets Daily
Amneal Pharmaceuticals Eyes 2026 Growth at JPMorgan, Crexont Sales Seen Doubling in 2025 - Daily Political
Tema Etfs LLC Purchases Shares of 93,166 Pfizer Inc. $PFE
Pfizer Inc. (NYSE:PFE) is favoured by institutional owners who hold 66% of the company
Bogart Wealth LLC Raises Holdings in Pfizer Inc. $PFE
Pfizer Inc. (NYSE:PFE) Given Consensus Rating of "Hold" by Analysts
TD Private Client Wealth LLC Has $5.95 Million Stock Position in Pfizer Inc. $PFE - Daily Political
ERN GENTURIS guideline on counselling on reproductive options for individuals with a cancer predisposition syndrome (including genturis)
Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial
Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra
UBS Likes Pfizer's MTSR Obesity Deal but Stays Neutral on PFE
Pfizer Talking to Trump Administration About Priority Vouchers
Dividend Stocks To Add to Your Watchlist - January 12th - Markets Daily
Pfizer Inc. $PFE Shares Sold by Bay Colony Advisory Group Inc d b a Bay Colony Advisors
Pfizer announces results from Cohort 3 of BREAKWATER trial | Markets Insider
Cohort 3 analysis from the BREAKWATER study shows objective
Madrigal Pharmaceuticals (MDGL) Is Down 13.4% After Pfizer MASH Deal And Wolfe Downgrade - What's Changed
Moderately bullish activity in Pfizer with shares up 0.38% | Markets Insider
Big Pharma turf war erupts: Bayer sues vaccine makers over alleged stolen mRNA technology - NaturalNews.com
Madrigal Expands its MASH Pipeline with Exclusive Global License Agreement for Ervogastat, a Phase 2 Oral DGAT-2 Inhibitor
Assessing Adaptive Biotechnologies (ADPT) Valuation After New Pfizer Deals And Digital Biotechnologies Financing
New study links COVID vaccines to autoimmune, cardiovascular and neurological damage-calls for immediate halt to gene-based shots - NaturalNews.com
Park Avenue Securities LLC Raises Stake in Pfizer Inc. $PFE - Daily Political
Monsanto Sues COVID-19 Vaccine Manufacturers, Alleging Copyright Infringement | ZeroHedge
Merck Negotiates $32 Billion Acquisition of Revolution Medicines to Boost Cancer Drug Pipeline, ETPharma
How Pfizer's AI and Precision Oncology Deals At Pfizer (PFE) Have Changed Its Investment Story
Merck in Talks to Buy Biotech Revolution Medicines, FT Says (2)
Top Undervalued Stocks to Watch in 2026 - IG UK
Top Undervalued Stocks to Watch in 2026 | IG South Africa
Pfizer Turns To AI Where Drug Risk Is Highest
Pfizer, Astellas Report Positive Phase 3 Trial Results for PADCEV Combination in Bladder Cancer Treatment
BioNTech (BNTX) Is Up 5.1% After 90%-Effective COVID Data Raises New Franchise Questions
Bayer sues Pfizer, Moderna, J&J and BioNTech over alleged Covid vaccine patent breach | Malay Mail
Clinical outcomes with perioperative nivolumab by nodal status in patients with stage III resectable NSCLC: phase 3 CheckMate 77T exploratory analysis
Bayer sues Covid-jab makers, alleging patent violation
KLP Kapitalforvaltning AS Grows Position in Pfizer Inc. $PFE
Top Pharmaceutical Stocks To Add to Your Watchlist - January 7th - Daily Political
Bayer's Monsanto Files Lawsuit Against Pfizer, BioNTech, and Moderna Over mRNA Patent Infringement, ETPharma
Big Pharma race to snap up biotech assets as $170 billion patent cliff looms
Securian Asset Management Inc. Decreases Stock Position in Pfizer Inc. $PFE - Daily Political
BioNTech (NasdaqGS:BNTX) Valuation Check After Positive COVID 19 Vaccine Efficacy Data
Alnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-human study
iShares Select Dividend Fund Has A Surprisingly High Yield For Retirees
Pfizer (NYSE:PFE) Stock Price Up 1.1% - Still a Buy? - Daily Political
Robeco Institutional Asset Management B.V. Has $290.44 Million Holdings in Pfizer Inc. $PFE - Markets Daily
Pfizer's 2026 Drug Price Reset Could Be A Game Changer For Pfizer (PFE)
Pfizer Inc. $PFE Position Cut by Commonwealth Equity Services LLC
Pfizer (PFE) Plans Price Increases on About 80 Medicines Despite Broader Pricing Deals
Clinical actionability in gliomas revealed by real-world next-generation sequencing: a multicentric study
Assessing Pfizer (PFE) Valuation After Recent Share Price Weakness And Dividend Support
ADPT: MRD Platform And Pfizer Agreements Will Support Long-Term Cash Flow Upside
Daymark Wealth Partners LLC Sells 52,529 Shares of Pfizer Inc. $PFE
Pfizer Inc. $PFE Shares Sold by Allen Wealth Management LLC
D.A. Davidson & CO. Acquires 70,161 Shares of Pfizer Inc. $PFE - Daily Political
Assessing Pfizer (PFE) Valuation As Recent Trading Momentum Shows Signs Of Slowing
Capital Advisors Inc. OK Grows Stake in Pfizer Inc. $PFE
Verity & Verity LLC Has $32.72 Million Stock Holdings in Pfizer Inc. $PFE - Markets Daily
Pfizer Inc. $PFE Shares Sold by Financiere des Professionnels Fonds d investissement inc. - Markets Daily
Pharmaceutical Stocks To Keep An Eye On - January 3rd - Stock Observer
Pfizer Inc. $PFE Shares Purchased by Verity & Verity LLC - Stock Observer
Financiere des Professionnels Fonds d investissement inc. Sells 22,061 Shares of Pfizer Inc. $PFE - Stock Observer
Elevated non-clonal bone marrow plasma cell fraction at diagnosis is associated with improved outcomes in multiple myeloma
Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial
Moderately bullish activity in Pfizer with shares up 1.1% | Markets Insider
Dividend Stocks To Follow Now - January 2nd - Markets Daily
Pfizer (PFE) Navigates Patent Losses With Strategic Cost Controls, BMO Capital Reaffirms Outperform Rating
Cough syrup controversy: Segment sees a "cautious" shift by consumers and doctors, say industry -watchers
Tectonic Advisors LLC Buys 49,737 Shares of Pfizer Inc. $PFE - Stock Observer
Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump - Yahoo News Canada
Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancer
Drug Prices Surge: 350 Medications Facing Increases Amid Trump Administration Pressure, ETPharma
Brokers Set Expectations for Pfizer's Q4 Earnings (NYSE:PFE)
Pfizer Inc. $PFE Shares Purchased by Ascent Group LLC
Promising Dividend Stocks Worth Watching - December 31st - Markets Daily
Despite Trump pressure, Big Pharma is raising hundreds of drug prices - Yahoo News Canada
Drugmakers hike US prices on 350 medicines despite pressure from Trump
Pfizer and GSK Lead 2026 U.S. Drug Price Hikes
Lupin's Bofanglutide: A Game-Changer in India's Weight-Loss and Diabetes Market, ETPharma
Pfizer (PFE) Braces for Bumpy Years as Growth Pushed Out to 2029
The Skin of Color Society (SOCS) Reports an Impactful Year of Progress, Expansion, and Innovation Toward Advancing Knowledge and Excellence in Patient Care
The past three years for Pfizer (NYSE:PFE) investors has not been profitable
Pfizer Inc. $PFE Shares Acquired by Fort Washington Investment Advisors Inc. OH
Mattson Financial Services LLC Has $665,000 Stock Position in Pfizer Inc. $PFE - Stock Observer
Option traders moderately bearish in Pfizer with shares down 0.14% | Markets Insider
Live Oak Private Wealth LLC Has $449,000 Stake in Pfizer Inc. $PFE
Ethic Inc. Lowers Holdings in Pfizer Inc. $PFE | MarketBeat
Live Oak Private Wealth LLC Reduces Stock Position in Pfizer Inc. $PFE - Daily Political
Top Pharmaceutical Stocks To Follow Now - December 28th - Stock Observer
Pfizer Inc. $PFE Shares Sold by Meyer Handelman Co.
